Page last updated: 2024-11-01

ofloxacin and Dyspnea

ofloxacin has been researched along with Dyspnea in 8 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"Tracheal rhinoscleroma is an infectious granulomatosis of the tracheobronchial tract caused by a Gram-negative bacillus."1.43Tracheal rhinoscleroma. ( Bartolomeo, M; Bigi, A; Costes, V; Makeieff, M, 2016)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schuster, S1
Diethelm, M1
Bigi, A1
Bartolomeo, M1
Costes, V1
Makeieff, M1
Schuette, W1
Nagel, S1
von Weikersthal, LF1
Pabst, S1
Schumann, C1
Deuss, B1
Salm, T1
Roscher, K1
Dickgreber, N1
Ferrufino, E1
Mejía, C1
Ortiz de la Tabla, V1
Chiner, E1
Paleiron, N1
Nguyen, BV1
Commandeur, D1
Danguy des Déserts, M1
Rioualen, S1
Ralec, B1
André, M1
Ould-Ahmed, M1
Rousset, J1
Berkowitz, DM1
Bechara, RI1
Wolfenden, LL1
Aviles, RJ1
Dockrell, DH1
Thompson, RL1
Kinoshita, M1
Kawaguchi, S1
Higuchi, E1
Ichikawa, Y1
Oizumi, K1

Trials

1 trial available for ofloxacin and Dyspnea

ArticleYear
Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:12

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chem

2011

Other Studies

7 other studies available for ofloxacin and Dyspnea

ArticleYear
[Achilles heel of COPD].
    Praxis, 2013, Jul-03, Volume: 102, Issue:14

    Topics: Achilles Tendon; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aza Compounds; Diagnosis, Di

2013
Tracheal rhinoscleroma.
    European annals of otorhinolaryngology, head and neck diseases, 2016, Volume: 133, Issue:1

    Topics: Anti-Bacterial Agents; Dyspnea; Female; Humans; Laser Therapy; Middle Aged; Ofloxacin; Rhinoscleroma

2016
Empyema caused by Legionella pneumophila.
    Archivos de bronconeumologia, 2012, Volume: 48, Issue:3

    Topics: Acute-Phase Proteins; Aged; Antigens, Bacterial; beta-Lactams; Body Fluids; Cough; Drug Therapy, Com

2012
[Miliary X-ray pattern is not always related to tuberculosis].
    Medecine et maladies infectieuses, 2013, Volume: 43, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Combined Modality Therapy; Device Remov

2013
An unusual cause of cough and dyspnea in an immunocompromised patient.
    Chest, 2007, Volume: 131, Issue:5

    Topics: Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Bordetella bronchiseptica; Bordet

2007
52-year-old man with shortness of breath.
    Mayo Clinic proceedings, 2000, Volume: 75, Issue:4

    Topics: Anti-Infective Agents; Community-Acquired Infections; Diagnosis, Differential; Dyspnea; Humans; Male

2000
[A case of dimethyl sulfate intoxication manifested by persistent dyspnea].
    Nihon Kyobu Shikkan Gakkai zasshi, 1992, Volume: 30, Issue:5

    Topics: Adult; Bronchi; Bronchopneumonia; Bronchoscopy; Ceftazidime; Drug Therapy, Combination; Dyspnea; Hum

1992